Literature DB >> 12859723

Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension.

Yasunao Miyamoto1, Kazuhiko Oho, Masafumi Kumamoto, Atsushi Toyonaga, Michio Sata.   

Abstract

BACKGROUND AND AIM: Balloon-occluded retrograde transvenous obliteration (B-RTO) is a novel therapeutic method for the treatment of large gastric fundal varices with spontaneous splenorenal shunt (SRS). However, the effects of B-RTO on liver function remain unknown.
METHODS: Fourteen patients with portal hypertension and gastric varices with SRS were studied, consisting of four patients with acute bleeding, five with high-risk varices, and five with refractory portosystemic encephalopathy. Hepatic venous catheterization was performed to evaluate hepatic blood flow and liver function using the continuous indocyanine green (ICG) infusion method. To assess the metabolic activity of the hepatocyte, the intrinsic clearance of ICG was calculated. In all patients, endoscopic study was performed before and 1 week and 1 month after the B-RTO, and followed every 6 months thereafter. After baseline measurements, B-RTO was performed. Four weeks after the B-RTO, the same catheter measurements were repeated.
RESULTS: The B-RTO was successful in all patients. Contrast-enhanced computed tomography showed complete obliteration of the SRS prior to the follow-up measurements. Endoscopic eradication of the fundal varices was obtained 6 months after B-RTO in all patients and encephalopathy was improved within 1 week after B-RTO. Following the B-RTO, hepatic blood flow (441 +/- 214 vs 668 +/- 299 mL/min, P < 0.0001) and the intrinsic clearance of ICG (233 +/- 123 vs 285 +/- 148 mL/min, P < 0.05) were significantly increased. Furthermore, intrahepatic resistance decreased after the B-RTO (P < 0.005).
CONCLUSION: From short-term assessment, B-RTO increases hepatic blood flow and improves the metabolic activity of the liver in patients with portal hypertension.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12859723     DOI: 10.1046/j.1440-1746.2003.03087.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  30 in total

1.  Clinical analysis of surgical treatment of portal hypertension.

Authors:  Xin-Bao Xu; Jing-Xiu Cai; Xi-Sheng Leng; Jia-Hong Dong; Ji-Ye Zhu; Zhen-Ping He; Fu-Shun Wang; Ji-Run Peng; Ben-Li Han; Ru-Yu Du
Journal:  World J Gastroenterol       Date:  2005-08-07       Impact factor: 5.742

2.  Changes in liver perfusion and function before and after percutaneous occlusion of spontaneous portosystemic shunt.

Authors:  Yasukazu Kako; Koichiro Yamakado; Wataru Jomoto; Toshiya Nasada; Koichiro Asada; Haruyuki Takaki; Kaoru Kobayashi; Takashi Daimon; Shozo Hirota
Journal:  Jpn J Radiol       Date:  2017-05-13       Impact factor: 2.374

3.  Transjugular Intrahepatic Portosystemic Shunt (TIPS) versus Balloon-occluded Retrograde Transvenous Obliteration (BRTO) for the Management of Gastric Varices.

Authors:  Wael E A Saad; Michael D Darcy
Journal:  Semin Intervent Radiol       Date:  2011-09       Impact factor: 1.513

4.  The History and Evolution of Balloon-occluded Retrograde Transvenous Obliteration (BRTO): From the United States to Japan and Back.

Authors:  Wael E A Saad
Journal:  Semin Intervent Radiol       Date:  2011-09       Impact factor: 1.513

5.  Simultaneous combined balloon-occluded retrograde transvenous obliteration and partial splenic embolization for gastric fundal varices.

Authors:  Nobuo Waguri; Akihiko Osaki; Shunzo Ikarashi; Masahiro Ogawa; Naosuke Kuraoka; Kohei Ogawa; Munehiro Sato; Tsuneo Aiba; Osamu Yoneyama; Koichi Furukawa; Kazuhito Sugimura; Kentarou Igarashi
Journal:  United European Gastroenterol J       Date:  2015-04-09       Impact factor: 4.623

Review 6.  Evidence-based clinical practice guidelines for liver cirrhosis 2015.

Authors:  Hiroshi Fukui; Hidetsugu Saito; Yoshiyuki Ueno; Hirofumi Uto; Katsutoshi Obara; Isao Sakaida; Akitaka Shibuya; Masataka Seike; Sumiko Nagoshi; Makoto Segawa; Hirohito Tsubouchi; Hisataka Moriwaki; Akinobu Kato; Etsuko Hashimoto; Kojiro Michitaka; Toshikazu Murawaki; Kentaro Sugano; Mamoru Watanabe; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2016-05-31       Impact factor: 7.527

7.  Index of convexity: a novel liver function index using Tc-GSA scintigraphy.

Authors:  Kenji Miki; Yuichi Matsui; Masanori Teruya; Michio Kaminishi; Norihiro Kokudo
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

8.  The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration.

Authors:  Nobuhiko Hiraga; Hiroshi Aikata; Shintaro Takaki; Hideaki Kodama; Hiroo Shirakawa; Michio Imamura; Yoshiiku Kawakami; Shoichi Takahashi; Naoyuki Toyota; Katsuhide Ito; Shinji Tanaka; Mikiya Kitamoto; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2007-08-24       Impact factor: 7.527

9.  Balloon-occluded retrograde transvenous obliteration of gastric varices: concept, basic techniques, and outcomes.

Authors:  Wael E A Saad
Journal:  Semin Intervent Radiol       Date:  2012-06       Impact factor: 1.513

10.  The short-term effects of balloon-occluded retrograde transvenous obliteration, for treating gastric variceal bleeding, on portal hypertensive changes: a CT evaluation.

Authors:  Sung Ki Cho; Sung Wook Shin; Eun Young Yoo; Young Soo Do; Kwang Bo Park; Sung Wook Choo; Heon Han; In Wook Choo
Journal:  Korean J Radiol       Date:  2007 Nov-Dec       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.